Benitec Biopharma Inc. (BNTC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
13.70
-0.10 (-0.72%)
At close: Sep 26, 2025, 3:59 PM
13.70
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Benitec Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
97.74M 50.87M 2.48M 4.06M 19.77M
Short-Term Investments
n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
83K 87K 122K 160K 194K
Receivables
33K 229K 55K 3K 25K
Inventory
n/a n/a 13K n/a n/a
Other Current Assets
741K 579K 1.18M 14K 15K
Total Current Assets
98.52M 51.67M 3.73M 4.82M 20.61M
Property-Plant & Equipment
991K 449K 613K 993K 577K
Goodwill & Intangibles
n/a n/a n/a n/a n/a
Total Long-Term Assets
1.07M 536K 735K 1.15M 771K
Total Assets
99.59M 52.21M 4.46M 5.97M 21.38M
Account Payables
1.02M 1.35M 1.14M 422K 274K
Deferred Revenue
n/a n/a n/a n/a n/a
Short-Term Debt
n/a 284K 275K 252K 213K
Other Current Liabilities
426K 2.39M 197K 148K 63K
Total Current Liabilities
1.8M 4.92M 3.98M 2.53M 1.37M
Long-Term Debt
n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 38K n/a n/a n/a
Total Long-Term Liabilities
495K 38K 284K 559K n/a
Total Liabilities
2.3M 4.96M 4.26M 3.09M 1.37M
Total Debt
849K 284K 559K 811K 213K
Book Value
97.3M 47.25M 202K 2.88M 20.01M
Book Value Per Share
2.69 4.60 0.15 1.50 19.80
Common Stock
2K 1K n/a 1K 1K
Retained Earnings
-228.18M -190.26M -167.89M -148.33M -130.12M
Comprehensive Income
-839K -892K -830K -1.25M -1.46M
Shareholders Equity
97.3M 47.25M 202K 2.88M 20.01M
Total Investments
n/a n/a n/a n/a n/a